5 pharma ‘Buy’ recommendations by Goldman Sachs, with up to 36% upside potential
- Posted on June 25, 2025
- By Financial Express
- 2 Views
5 pharma ‘Buy’ recommendations by Goldman Sachs, with up to 36% upside potential
Explore Goldman Sachs' top 5 Indian pharma stock picks with up to 36% upside - see the full recommendations now!
